Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 3. Rapid correction of low vitamin D status in nursing home residents 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
Continuous Glucose Monitoring Health Outcomes
Diabetes Technology & Therapeutics, 06/04/09
Edelman SV et al. - Continuous glucose monitoring (CGM) is a new tool that has recently become available to people with diabetes. Recent data using real-time CGM suggest significant improvements in important clinical outcomes such as hemoglobin A1c, time spent in the hypo- and hyperglycemic range, glucose variability, quality of life, and perceived value to physicians and patients. Additional variables such as age of the subject and duration of sensor use have important implications in defining the benefits of CGM in a heterogeneous population with diabetes.
Related Articles
Effectiveness of Continuous Glucose Monitoring in a Clinical Care Environment: Evidence from the JDRF-CGM Trial
Diabetes Care, 10/30/09
Relevance Score: 87%
Improved Quality of Glycemic Control and Reduced Glycemic Variability with Use of Continuous Glucose Monitoring
Diabetes Technology & Therapeutics, 11/17/09
Relevance Score: 84%
Continuous Glucose Monitor Shows Potential for Early Hypoglycemia Detection in Hospitalized Patients
Diabetes Technology & Therapeutics, 11/18/09
Relevance Score: 80%
Today in Diabetes...keeping you current
Receive free subspecialty "5-minute updates" via email
Individuation of different metabolic phenotypes in normal glucose tolerance test
Acta Diabetologia, 11/25/09
Psychometric properties and responsiveness of the Turkish version of the Diabetes Treatment Satisfaction Questionnaire (s) on a sample of diabetics of three consecutive monitoring periods
Acta Diabetologia, 11/25/09
Serum glycated albumin, but not glycated haemoglobin, is low in relation to glycemia in hyperuricemic men
Acta Diabetologia, 11/25/09
Today in Diagnostics...keeping you current
Receive free subspecialty "5-minute updates" via email
Limited Value of 18F-F-DOPA PET to Localize Pancreatic Insulin-Secreting Tumors in Adults with Hyperinsulinemic Hypoglycemia
Journal of Clinical Endocrinology and Metabolism, 11/25/09
A Comparison Between Diagnostic I-123 and Posttherapy I-131 Scans in the Detection of Remnant and Locoregional Thyroid Disease
Clinical Nuclear Medicine , 11/25/09
F-18 FDG-PET/CT Evaluation of Patients With Differentiated Thyroid Cancer With Negative I-131 Total Body Scan and High Thyroglobulin Level
Clinical Nuclear Medicine , 11/25/09
Sponsor
Article Search
Sponsor


See Latest Articles


